Feifei Chen

566 total citations
19 papers, 425 citations indexed

About

Feifei Chen is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Feifei Chen has authored 19 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Feifei Chen's work include Cancer-related molecular mechanisms research (7 papers), Extracellular vesicles in disease (3 papers) and MicroRNA in disease regulation (3 papers). Feifei Chen is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Extracellular vesicles in disease (3 papers) and MicroRNA in disease regulation (3 papers). Feifei Chen collaborates with scholars based in China and United States. Feifei Chen's co-authors include Junnian Zheng, Jin Bai, Jiehui Di, Hui Liu, Chen Li, Zhen‐Qiang Pan, Peng-jin Mei, Dong‐Sheng Pei, Zhenhua Yang and Wei Gu and has published in prestigious journals such as PLoS ONE, Journal of Investigative Dermatology and Cancer Letters.

In The Last Decade

Feifei Chen

18 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feifei Chen China	11	302	186	67	57	45	19	425
Feiya Du China	12	284 0.9×	199 1.1×	80 1.2×	22 0.4×	25 0.6×	16	428
Qingjiang Chen China	9	236 0.8×	161 0.9×	86 1.3×	72 1.3×	17 0.4×	27	358
Jianwen Wang China	9	207 0.7×	111 0.6×	43 0.6×	23 0.4×	26 0.6×	27	328
Jinjing Tan China	11	176 0.6×	123 0.7×	104 1.6×	18 0.3×	22 0.5×	28	295
Shaoqing Ju China	16	372 1.2×	402 2.2×	91 1.4×	67 1.2×	48 1.1×	29	555
Yingfeng Zhu China	10	338 1.1×	200 1.1×	74 1.1×	17 0.3×	47 1.0×	17	459
Jintong Ji China	10	192 0.6×	100 0.5×	81 1.2×	31 0.5×	32 0.7×	12	303
Areeg Faggad Sudan	12	268 0.9×	164 0.9×	96 1.4×	23 0.4×	33 0.7×	18	406
Xiaojing Jia China	13	262 0.9×	202 1.1×	84 1.3×	30 0.5×	70 1.6×	19	419
Xuanfu Xu China	13	367 1.2×	156 0.8×	161 2.4×	38 0.7×	33 0.7×	19	499

Countries citing papers authored by Feifei Chen

Since Specialization

Citations

This map shows the geographic impact of Feifei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Chen more than expected).

Fields of papers citing papers by Feifei Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Chen. The network helps show where Feifei Chen may publish in the future.

Co-authorship network of co-authors of Feifei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Chen. A scholar is included among the top collaborators of Feifei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Chen. Feifei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zhang, Rongrong, et al.. (2025). Human-induced pluripotent stem cell-derived exosomes promote skin wound healing through activating FGF2-mediated p38 pathway. Molecular and Cellular Biochemistry. 480(7). 4227–4242. 4 indexed citations

Wang, Jinjin, Xingzhi Jing, Xiaoyang Liu, et al.. (2024). Naringin safeguards vertebral endplate chondrocytes from apoptosis and NLRP3 inflammasome activation through SIRT3-mediated mitophagy. International Immunopharmacology. 140. 112801–112801. 8 indexed citations

Chen, Feifei, et al.. (2024). N6-Methyladenosine Modification of lncCCKAR-5 Regulates Autophagy in Human Umbilical Cord Mesenchymal Stem Cells by Destabilizing LMNA and Inhibits Diabetic Wound Healing. Journal of Investigative Dermatology. 144(5). 1148–1160.e15. 7 indexed citations

Chen, Feifei, et al.. (2023). Promote lipolysis in white adipocytes by magnetic hyperthermia therapy with Fe₃O₄ microsphere-doped hydrogel. Nanotechnology. 35(15). 155101–155101. 4 indexed citations

Yuan, Yuan, et al.. (2023). Identification of an Exosome-relevant SNHG6-hsa-miR-429-CHRDL1/CCNA2 Axis for Lung Adenocarcinoma PrognosisEvaluation. Current Medicinal Chemistry. 31(28). 4549–4561. 4 indexed citations

Yuan, Yuan, et al.. (2022). SIX5-activated LINC01468 promotes lung adenocarcinoma progression by recruiting SERBP1 to regulate SERPINE1 mRNA stability and recruiting USP5 to facilitate PAI1 protein deubiquitylation. Cell Death and Disease. 13(4). 312–312. 16 indexed citations

Chen, Jing, Yuan Yuan, Surong Fang, et al.. (2021). Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma. Cancer Letters. 526. 142–154. 59 indexed citations

Chen, Feifei, et al.. (2021). Circular RNA ubiquitin-associated protein 2 enhances autophagy and promotes colorectal cancer progression and metastasis via miR-582-5p/FOXO1 signaling. Journal of genetics and genomics. 48(12). 1091–1103. 27 indexed citations

Li, Qiang, et al.. (2018). miR-5591-5p regulates the effect of ADSCs in repairing diabetic wound via targeting AGEs/AGER/JNK signaling axis. Cell Death and Disease. 9(5). 566–566. 33 indexed citations

10.

Li, Shuofeng, et al.. (2017). The Emerging Roles of RASSF5 in Human Malignancy. Anti-Cancer Agents in Medicinal Chemistry. 18(3). 314–322. 15 indexed citations

11.

Xu, Qian, Ji Wang, Feifei Chen, et al.. (2016). Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms. International Journal of Molecular Medicine. 38(1). 275–282. 23 indexed citations

12.

Chen, Feifei, Xin Liu, Qian Cheng, et al.. (2016). RUNX3 regulates renal cell carcinoma metastasis via targeting miR-6780a-5p/E-cadherin/EMT signaling axis. Oncotarget. 8(60). 101042–101056. 24 indexed citations

13.

Zhu, Yunxia, Qiliang Peng, Yuxin Lin, et al.. (2016). Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network. Oncotarget. 8(2). 2233–2248. 40 indexed citations

14.

Chen, Feifei, Meng Wang, Jin Bai, et al.. (2014). Role of RUNX3 in Suppressing Metastasis and Angiogenesis of Human Prostate Cancer. PLoS ONE. 9(1). e86917–e86917. 39 indexed citations

15.

Zhu, Wen, Wangjian Zha, Feifei Chen, et al.. (2014). Expression profiles and initial confirmation of long noncoding RNAs in Chinese patients with pulmonary adenocarcinoma. OncoTargets and Therapy. 7. 1195–1195.

16.

Bai, Jin, Peng-jin Mei, Feifei Chen, et al.. (2013). BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer. PLoS ONE. 8(3). e59772–e59772. 79 indexed citations

17.

Chen, Feifei, Jian Song, Jiehui Di, et al.. (2012). IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation. Tumor Biology. 33(6). 2217–2225. 10 indexed citations

18.

Tian, Hui, Wang Li, Feifei Chen, et al.. (2010). A critical role of Sp1 transcription factor in regulating the human Ki-67 gene expression. Tumor Biology. 32(2). 273–283. 24 indexed citations

19.

Pei, Dong‐Sheng, Jiehui Di, Feifei Chen, & Junnian Zheng. (2010). Oncolytic-adenovirus-expressed RNA interference for cancer therapy. Expert Opinion on Biological Therapy. 10(9). 1331–1341. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact